raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:84142

Isaacs syndrome

Synonyms: Continuous muscle fiber activity syndrome · Isaacs-Mertens syndrome · Quantal squander syndrome

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

Isaac's syndrome is an immune-mediated peripheral motor neuron disorder characterized by continuous muscle fiber activity at rest resulting in muscle stiffness, cramps, myokymia, and pseudomyotonia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enIsaacs syndromeContinuous muscle fiber activity syndrome · Isaacs-Mertens syndrome · Quantal squander syndrome
frSyndrome d'IsaacsSyndrome d'Isaacs-Mertens · Syndrome d'activité continue des fibres musculaires
deIsaacs-SyndromQuantal-Squander-Syndrom · Syndrom der kontinuierlichen Muskelfaseraktivität · Isaac-Mertens-Syndrom
esSíndrome de IsaacsSíndrome de Isaacs-Mertens · Síndrome de actividad continua de la fibra muscular
itSindrome di IsaacSindrome "quantal squander" · Sindrome da attività continua delle fibre muscolari · Sindrome di Isaac-Mertens · Sindrome “quantal squander”
nlSyndroom van IsaacsContinue spiervezelactiviteit-syndroom · Quantal squander-syndroom · Syndroom van Isaacs-Mertens
ptSíndrome IsaacsSíndrome Isaacs-Mertens · Síndrome de actividade contínua das fibras musculares
plZespół IsaacaNadpobudliwość nerwów obwodowych · Neuromiotonia nabyta · Quantal squander syndrome · Zespół Isaaca i Mertensa · Zespół stałej aktywności włókien mięśniowych
csIsaacův syndromZískaná neuromyotonie · Syndrom trvalé aktivity svalových vláken · Periferní nervová hyperexcitabilita · Isaacův-Mertensův syndrom · Isaac-Mertensův syndrom
ukСиндром ІсаакаСиндром безперервної активності мязових волокон · Синдром Айзека-Мертенса · Синдром квантального марнотратства
zhIsaac综合征持续性肌纤维活动综合征
trIsaac sendromuEdinsel nöromiyotoni · Isaac-Mertens sendromu · Quantal skandal sendromu · Sürekli kas lifi aktivite sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G71.1NTBTinclusionvalidated
ICD-118C71.4Especificvalidated
MONDO0019399Evalidated
MeSHD020386Evalidated
UMLSC0242287Evalidated
GARD6793Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families150 casesWorldwideCase(s)Validated[EXPERT]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2016-08-09
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:5000005Anti-CASPR2
HP:0008981Calf muscle hypertrophy
HP:0002353EEG abnormality
HP:0100288EMG: myokymic dischargesDiagnostic criterion
HP:0002380Fasciculations
HP:0000975HyperhidrosisDiagnostic criterion
HP:0010546Muscle fibrillation
HP:0003394Muscle spasmDiagnostic criterion
HP:0003552Muscle stiffness
HP:0002411MyokymiaDiagnostic criterion
HP:0001824Weight lossDiagnostic criterion
Occasional (29-5%)
HP:0002936Distal sensory impairment
Very rare (<4-1%)
HP:0001324Muscle weakness

Annotation source: 25736532[PMID]

7

Sources for this card